What Is It?
Vardenafil is a prescription PDE5 inhibitor approved in 2003. It is available as a standard tablet and, in some markets, an orally disintegrating tablet.
Product Profile & Review
A potent, highly selective PDE5 inhibitor with a profile similar to sildenafil and an orally disintegrating form.
Also known as: Levitra (brand), Staxyn (ODT brand)
Vardenafil is a prescription PDE5 inhibitor approved in 2003. It is available as a standard tablet and, in some markets, an orally disintegrating tablet.
A claimed ingredient is what a label or seller states. It is not treated as confirmed.
Established
Uncertain or unverified
Sexual stimulation releases nitric oxide (NO) in penile tissue. NO raises levels of cyclic GMP (cGMP), which relaxes the smooth muscle of the corpus cavernosum so arteries widen and blood flows in.
The enzyme PDE5 normally breaks cGMP down. PDE5 inhibitors block that enzyme, so cGMP persists and smooth-muscle relaxation is sustained. They do not create arousal—stimulation is still required.
Grades run from A (strong clinical evidence) to F (unsupported or contradicted). How we grade.
Common effects
Headache, flushing, nasal congestion, indigestion and dizziness.
FDA-approved for erectile dysfunction.
SynMale scores are editorial comparison tools and are not medical efficacy guarantees.
SynMale numerical ratings are editorial comparison tools informed by:
These numbers are not efficacy percentages, clinical success rates, or predictions of individual response.
Full methodology →A well-studied alternative with a profile close to sildenafil.
Vardenafil works much like sildenafil, with a similar onset and duration. It is a reasonable alternative for some patients, guided by a clinician. Standard PDE5 safety rules apply, plus caution with heart-rhythm drugs.